Compounded tirzepatide
Recorded for Luma Meds · Sublingual · every compounded tirzepatide record
Price
Historical price evidence from September 2026. Current availability and prices are not verified. These figures are not a current offer.
| Term | Per month | Charged today |
|---|---|---|
| Tirzepatide ODT Pills Rx, starting price “Needle-Free from $272 /mo Tirzepatide ODT Pills Rx Dual GLP-1 + GIP Receptor Agonist - Oral Dissolving Tablet” | Per month$272 | Charged today$272 |
Price sources
- Tirzepatide ODT Pills Rx, starting price · lumameds.com — read September 2026
Current availability of this program is not verified.
We earn nothing from this link. It opens Luma Meds's website without a paid referral.
History
Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.
- September 2026 — Entry added to the register
Sourcing and terms
| Prescriber | Asynchronous review |
|---|---|
| Cancellation | Cancel Anytime ... Get Started Today No insurance required · Cancel anytime · 100% online |
| Membership | None. “No membership or hidden fees” |
Not yet checked: pharmacy, states and consult fee.
Recorded from lumameds.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2026 — The FAQ page contains the question 'What states does Luma service?' but its answer text is not present in the rendered static HTML fetch_site.py returns (likely a JS accordion), so no state list or 'all 50 states' claim could be confirmed despite the question existing.
- 2. October 2026 — Luma’s current public treatment pages could not be verified. Confirm the current program, price and terms directly before enrolling; the previously recorded offer should not be treated as a current quote.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.